Comparison of benzotriazole ultraviolet stabilizers (BUVs) removal from wastewater after subsequent stages of sequencing batch reactor (SBR) treatment process

The research focused on benzotriazole ultraviolet stabilizers (BUVs) which are commonly used compounds despite being found dangerous, e.g. promoting breast cancer cell proliferation, damaging vital organs such as hearts, brains livers and kidneys. The aim of the study was to analyse the efficiency and removal rate of BUVs from wastewater depending on the quantity of tested compounds and SBR anaerobic -aerobic conditions. The study was conducted in sequencing batch reactors (SBRs - 17 L) with real flocculent activated sludge (8 L) and model wastewater (5 L) containing UV -326, UV -327, UV -328, UV -329 and UV -P from 50 to 600 mu g center dot L-1. The SBR were operated in 390 cycles of 7 h and 10 min over 130 days. The similarity of the technological parameters of the treatment process to those used in a real wastewater treatment plant was maintained. Efficiency removal of individual BUVs was strictly dependent on the dose of compounds introduced into wastewater and ranged from 68.2 to 97 %. Removal of UV -329 occurred with lowest efficiency (from 68.2 to 85.2 %) while UV -326 was most efficiently removed from the wastewater (from 94.1 to 97 %). UV -329 was removed from wastewater with the lowest (0.0968-0.9524 mu g center dot L-1 center dot min- 1) average removal rate while UV -327 with the highest (0.16-1.3357 mu g center dot L-1 center dot min- 1), irrespective of BUVs dose in the influent. Secondary release of BUVs into the wastewater occurred in SBR during the settling phase and was dependent on the type and concentration of the BUVs in the raw wastewater. This occurrence was noted for UV -326 >= 100; UV -327 = 600; UV -328 >= 200; UV -329 >= 50 and UV -P >= 100 mu g center dot L-1. The settling phase needs to be shortened to the required minimum. This is an important conclusion for WWTPs in regards to SBR cycle duration and technological parameters of the treatment process.